BNTCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Benitec Biopharma Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 14, 2026
$8.36+0.25 (+3.08%)
Close on Oct 19, 2026
- Market cap
- $413.29M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 14, 2025(first seen in filings) | 9-for-2 | Earlier per-share figures divided by 4.5 |
| Jul 26, 2023 | 1-for-17 reverse | Earlier per-share figures multiplied by 17 |
| Apr 15, 2020 | 1-for-1.5 reverse | Earlier per-share figures multiplied by 1.5 |
| Nov 18, 2019 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jun 16, 2015 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |